{
    "code": "52026934",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026934",
    "time": "2020-07-17 03:16:28",
    "許可證字號": "衛部藥輸字第026934號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/09\/07",
    "發證日期": "105\/09\/07",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202693403",
    "中文品名": "樂衛瑪膠囊10毫克",
    "英文品名": "Lenvima Capsules 10 mg",
    "適應症": "1. 分化型甲狀腺癌(Differentiated thyroid cancer, DTC): 適用於放射性碘治療無效之進行性，且為局部晚期或轉移性之分化型甲狀腺癌之成人病人。\r\n2. 腎細胞癌(Renal Cell Carcinoma, RCC): 適用於和everolimus併用治療曾經接受過一種抗血管新生療法的晚期腎細胞癌病人。\r\n3. 肝細胞癌(Hepatocellular Carcinoma): 適用於無法手術切除且不適合局部治療之晚期肝細胞癌病人。\r\n4. 子宮內膜癌(Endometrial Carcinoma): 與pembrolizumab併用適用於曾經接受過全身性治療後疾病惡化，且不適合根治手術或放射治療的不具有高微衛星不穩定性(microsatellite instability-high, MSI-H)或錯誤配對修復功能不足(mismatch repair deficient, dMMR)之晚期子宮內膜癌病人。",
    "劑型": "130膠囊劑",
    "包裝": "4-1000粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "110\/09\/07",
    "主成分略述": "Lenvatinib mesilate",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "0407901100  衛采製藥股份有限公司",
    "申請商地址": "台北市長安東路一段十八號九樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0057000  KAWASHIMA PLANT OF EISAI CO.,LTD.",
            "製造廠廠址": "1,KAWASHIMATAKEHAYA-MACHI, KAKAMIGAHARA-SHI,GIFU-KEN,JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013005810",
            "成分名稱": "Lenvatinib mesilate",
            "含量描述": "",
            "含量": "12.2500000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "黃色\/黃紅色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "E",
        "標記二": "LENV 10 mg"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Lenvima 10mg capsule-106-06-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026934&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Lenvima Taiwan Chinese PI-109-06-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026934&Seq=013&Type=9"
        },
        {
            "title": "LEN10_Carton_TPE 20171225-107-12-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026934&Seq=005&Type=8"
        },
        {
            "title": "LEN PTP-107-12-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026934&Seq=004&Type=8"
        },
        {
            "title": "Lenvima 10mg Taiwan Foil-105-11-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026934&Seq=002&Type=8"
        }
    ]
}